Literature DB >> 1918999

Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.

P Rieckmann1, G Poli, C H Fox, J H Kehrl, A S Fauci.   

Abstract

The effect of recombinant protein from the envelope (gp120) of the HIV on B lymphocytes purified from either HIV-infected individuals or healthy seronegative controls was examined. B cells from peripheral blood and lymph nodes of HIV-infected individuals spontaneously secreted TNF-alpha; this secretion was augmented by the presence of gp120, whereas B cells from healthy seronegative donors failed to secrete significant levels of TNF-alpha in the presence or absence of gp120. In a coculture system of B cells and chronically HIV-infected T cells (ACH-2), where viral expression is largely mediated by TNF-alpha, gp120 increased virus expression only if the B cells were obtained from HIV-infected individuals. The effects of gp120 on viral expression in this system were not mediated via CD4 receptor binding or FcR binding of anti gp120-gp120 immune complexes. Besides its effect on cytokine production, gp120 also stimulated Ig secretion in B cells from HIV-infected individuals, but not from normal donors. Finally, it was demonstrated by in situ hybridization that germinal centers of lymph nodes from HIV-infected individuals contain large amounts of HIV RNA that is in close proximity to germinal center B cells. These findings suggest that the hyperplastic germinal centers of lymph nodes provide an unique environment for virus expression and accumulation where gp120 stimulates B cells to secrete HIV inductive cytokines, such as IL-6 and TNF-alpha, and thereby further enhances virus expression in infected cells in a paracrine manner.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918999

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Role of immune activation in HIV pathogenesis.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

Review 2.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

3.  AIDS - Associated Kaposi's Sarcoma: A Double Jeopardy.

Authors:  O Prakash; G H Porter
Journal:  Ochsner J       Date:  1999-04

4.  Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment.

Authors:  Michaël Imbeault; Michel Ouellet; Katia Giguère; Jonathan Bertin; Dave Bélanger; Geneviève Martin; Michel J Tremblay
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

Review 5.  Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Authors:  Anna Haas; Kathrin Zimmermann; Annette Oxenius
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

6.  A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individuals.

Authors:  Matthew Morrow; Antonio Valentin; Richard Little; Robert Yarchoan; George N Pavlakis
Journal:  AIDS Res Hum Retroviruses       Date:  2008-04       Impact factor: 2.205

7.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 8.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

Review 9.  Role of apoptosis in HIV disease pathogenesis.

Authors:  N Oyaizu; S Pahwa
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

10.  Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines.

Authors:  F Ameglio; M R Capobianchi; C Castilletti; P Cordiali Fei; S Fais; E Trento; F Dianzani
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.